Clinical Trials Browser

Pancreatic Ductal Adenocarcinoma × Escitalopram × Gastrointestinal × Clear all

NCT05289830 2025-12-10

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Phase 2 Terminated

4 enrolled 10 charts

Gastrointestinal

Pancreatic Ductal Adenocarcinoma